s.balogun

TL2 Moderator · Brno

Contributes reviews on supplier material. Based in Brno.

Joined 28 January 2025 · last posted 4d

73 posts, newest first. Showing up to 150.

Packaging that arrived damaged: documenting it properly Replied, post #48 · Sourcing › Logistics · 24 Jul 2026 · 6 likes post #47 is right about the mechanism and I think understates the practical bit. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #56 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 24 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #40 · Compounds › Retatrutide · 20 Jul 2026 · 0 likes Worth separating two things that post #36 runs together. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #46 · Access › Insurance & coverage · 19 Jul 2026 · 0 likes Worth separating two things that post #42 runs together. Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail…
A structured critique template this community uses — a second dataset Replied, post #40 · Evidence › Study critique · 16 Jul 2026 · 25 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
A pooled estimate that changed when one trial was added Replied, post #24 · Evidence › Meta-analyses · 16 Jul 2026 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #55 · Clinical › Comorbidities · 16 Jul 2026 · 11 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Journal club: what we got wrong in an earlier session Replied, post #80 · Evidence › Journal club · 13 Jul 2026 · 5 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
Constipation management, with a dietitian's contribution Replied, post #85 · Practice › Side effects · 28 Jun 2026 · 8 likes post #84 is right about the mechanism and I think understates the practical bit. Injection site reaction: local erythema, nodules, or induration at injection sites is…
Does dual agonism explain the effect size, or is it dose? Replied, post #37 · Compounds › Tirzepatide · 15 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #29 · Analytics › Home & field testing · 2 Jun 2026 · 9 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #83 · Practice › Side effects · 21 May 2026 · 3 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
Research-use-only status: what it means legally and practically Replied, post #36 · Compounds › Other compounds · 2 May 2026 · 10 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
Hair shedding at month three: mechanism and time course — the long version Replied, post #4 · Practice › Side effects · 28 Apr 2026 · 0 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #69 · Start Here › Welcome · 22 Apr 2026 · 24 likes Worth separating two things that post #65 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
[2026 update] Composite endpoints and the component doing the work Replied, post #65 · Evidence › Trials · 11 Apr 2026 · 28 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
Foaming during reconstitution and whether it matters — the long version Replied, post #80 · Practice › Reconstitution · 29 Mar 2026 · 2 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
Grapefruit: why this class is not the class that cares Replied, post #77 · Practice › Interactions · 25 Mar 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #108 · Practice › Interactions · 9 Feb 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #6 · Outcomes › Progress reports · 5 Feb 2026 · 7 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #27 · Research Methods › N-of-1 designs · 1 Feb 2026 · 3 likes post #26 is right about the mechanism and I think understates the practical bit. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #21 · Compounds › Oral incretins · 7 Jan 2026 · 19 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
What "verified" means on our vendor pages, stated narrowly Replied, post #28 · Sourcing › Vendor reports · 2 Jan 2026 · 12 likes On post #24 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #28 · Sourcing › Red flags · 27 Dec 2025 · 11 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #22 · Access › International · 23 Dec 2025 · 33 likes Coming back to post #20, because the follow-up matters more than the original answer. Customs and import outcomes: different routes have different seizure rates. Some…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #52 · Clinical › Special populations · 14 Dec 2025 · 4 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
Tracking a preprint to publication: a worked example Replied, post #71 · Evidence › Preprints · 7 Dec 2025 · 1 like This follows post #68 rather than contradicting it. Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #11 · Sourcing › Independent verification · 2 Dec 2025 · 0 likes post #10 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Tracking a preprint to publication: a worked example Replied, post #5 · Evidence › Preprints · 28 Nov 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Robustness: the parameters worth deliberately varying Replied, post #26 · Analytics › Method validation · 28 Nov 2025 · 1 like post #25 answers the question as asked. The question underneath it is different. Range: the concentration range over which the method has been validated. Going outside…
Can a home kit substitute for a laboratory report? A careful no Replied, post #58 · Analytics › Home & field testing · 20 Nov 2025 · 0 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
Thyroid function tests during substantial weight change Replied, post #113 · Clinical › Bloodwork · 28 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Managing an unplanned gap in supply — what changed since Replied, post #100 · Access › Shortages · 28 Oct 2025 · 0 likes post #99 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
Revisiting: German, French and Dutch differences, compared Replied, post #81 · Regional › European Union · 3 Oct 2025 · 11 likes post #80 answers the question as asked. The question underneath it is different. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands)…
Specification in the result column: why that is a meaningful error Replied, post #52 · Analytics › COA interpretation · 2 Oct 2025 · 2 likes Picking up post #49: that is the part I would want checked first. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That…
Documentation that materially improves an appeal's chances Replied, post #10 · Access › Insurance & coverage · 25 Sep 2025 · 3 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #9 · Compounds › Semaglutide · 20 Aug 2025 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
Asking about a compound your prescriber has not heard of Replied, post #128 · Clinical › Prescriber conversations · 16 Aug 2025 · 11 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
Revisiting: List price versus negotiated price versus what you pay Replied, post #19 · Access › Pricing · 8 Aug 2025 · 9 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #7 · Clinical › Special populations · 7 Aug 2025 · 26 likes On post #3 — agreed on the reasoning, with one qualification. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #47 · Practice › Dosing & titration · 5 Aug 2025 · 1 like post #46 answers the question as asked. The question underneath it is different. Dose equivalence between different incretin analogues is a weak concept. The molecules…
Are there stupid questions here? A staff answer, at length Replied, post #4 · Start Here › Welcome · 21 Jul 2025 · 26 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
What this community means by "a source", in practical terms Replied, post #28 · Start Here › Welcome · 8 Jul 2025 · 3 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #12 · Compounds › Semaglutide · 30 Jun 2025 · 32 likes post #11 is right about the mechanism and I think understates the practical bit. The mass figure differs between sources because of how the different entities report…
A comparison of home results against a laboratory result on the same vial Replied, post #5 · Analytics › Home & field testing · 13 Jun 2025 · 0 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
Specification in the result column: why that is a meaningful error Replied, post #8 · Analytics › COA interpretation · 13 Jun 2025 · 12 likes Coming back to post #6, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Subcutaneous absorption kinetics and site differences Replied, post #8 · Pharmacology › Pharmacokinetics · 12 Jun 2025 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 2 Jun 2025 · 0 likes Picking up post #3: that is the part I would want checked first. For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #11 · Compounds › Secretagogues & GH axis · 31 May 2025 · 17 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #11 · Evidence › Journal club · 21 May 2025 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #33 · Clinical › Comorbidities · 5 May 2025 · 22 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Follow-up: Documentation that appears only after payment Replied, post #38 · Sourcing › Red flags · 1 May 2025 · 6 likes Picking up post #35: that is the part I would want checked first. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #58 · Practice › Reconstitution · 27 Apr 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #42 · Compounds › Retatrutide · 25 Apr 2025 · 0 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #68 · Compounds › Tirzepatide · 23 Apr 2025 · 0 likes post #67 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #59 · Evidence › Journal club · 19 Apr 2025 · 7 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Retatrutide dose escalation in the published trials Replied, post #143 · Compounds › Retatrutide · 17 Apr 2025 · 25 likes Coming back to post #141, because the follow-up matters more than the original answer. Dose escalation in the published trials: the protocols started at lower doses and…
Certificates issued by the seller versus by a laboratory Replied, post #15 · Analytics › COA interpretation · 23 Mar 2025 · 27 likes I read post #13 twice before replying, because I had assumed the opposite. What fields matter on a certificate: lot number matching the vial, test date, the analytical…
A newcomer's list of things that confused me, and the fixes Replied, post #7 · Start Here › Welcome · 13 Mar 2025 · 24 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #60 · Compounds › Secretagogues & GH axis · 31 Jan 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What changed in 2026, by region Replied, post #99 · Access › International · 25 Jan 2025 · 0 likes I read post #97 twice before replying, because I had assumed the opposite. Country-by-country legality: compound approval and legal status differ substantially by…
Second pass at: Historical amylin analogues and what happened to them Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 18 Jan 2025 · 0 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #15 · Practice › Dosing & titration · 11 Jan 2025 · 24 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
Isotonicity and what happens when you get it wrong Replied, post #19 · Pharmacology › Formulation chemistry · 6 Jan 2025 · 22 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #9 · Access › Pricing · 31 Dec 2024 · 1 like This follows post #6 rather than contradicting it. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #81 · Compounds › Tirzepatide · 10 Dec 2024 · 16 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 13 Nov 2024 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #17 · Practice › Interactions · 16 Oct 2024 · 16 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Revisiting: How to bring a laboratory report to an appointment usefully Started this topic · Clinical › Bloodwork · 29 Aug 2024 · 41 likes Revisiting: How to bring a laboratory report to an appointment usefully — setting out what I have, and where I think it stops being reliable. General question, not a…
Promotion criteria, and the one that stops most nominations Replied, post #42 · Documentation › Doc review · 20 Aug 2024 · 25 likes post #41 answers the question as asked. The question underneath it is different. Interdependencies: if updating one page requires updating related pages, posting that…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #33 · Safety › Contraindications · 26 Jul 2024 · 9 likes Coming back to post #31, because the follow-up matters more than the original answer. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires…
Pen wastage and its effect on real cost Replied, post #9 · Access › Pricing · 20 Jul 2024 · 32 likes Worth separating two things that post #5 runs together. Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen…
Cold packs, phase-change material, and what survives ten days Replied, post #116 · Sourcing › Logistics · 17 Jul 2024 · 9 likes post #115 is right about the mechanism and I think understates the practical bit. Tracking stops updating: tracking last updated days ago usually means the package is…